Evidence map›Paper›PMID 32669936›Full record

ArticleCurrent oncology (Toronto, Ont.)2020

Investigating epidemiologic trends and the geographic distribution of patients with anal squamous cell carcinoma throughout Canada.

L Cattelan, F M Ghazawi, M Le, E Savin, A Zubarev, F Lagacé, D Sasseville, K Waschke, I V Litvinov

Open access · goldAbstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

L CattelanDepartment of Medicine, McGill University, Montreal, QC.
F M GhazawiDivision of Dermatology, University of Ottawa, Ottawa, ON.
M LeDivision of Dermatology, McGill University, Montreal, QC.
E SavinDivision of Dermatology, McGill University, Montreal, QC.
A ZubarevDivision of Dermatology, McGill University, Montreal, QC.
F LagacéDepartment of Medicine, McGill University, Montreal, QC.
D SassevilleDivision of Dermatology, McGill University, Montreal, QC.
K WaschkeDivision of Gastroenterology, McGill University, Montreal, QC.
I V LitvinovDivision of Dermatology, McGill University, Montreal, QC.
McGill University · CAUniversity of Ottawa · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Anal cancer is a rare disease, constituting 0.5% of new cancer cases in the United States. The most common subtype is squamous cell carcinoma (scc). Studies in several developed nations have reported on an increasing incidence of anal cancer in recent decades, and various risk factors pertaining to the pathogenesis of the disease have been identified, including infection with the human papillomavirus, tobacco use, and immunosuppression. The epidemiology and distribution of anal scc throughout Canada remain poorly understood, however. Methods: Using 3 population-based cancer registries, a retrospective analysis of demographic data across Canada for 1992-2010 was performed. The incidence and mortality for anal scc was examined at the levels of provinces, cities, and the forward sortation area (FSA) component (first 3 characters) of postal codes. Results: During 1992-2010, 3720 individuals were diagnosed with anal scc in Canada; 64% were women. The overall national incidence rate was 6.3 cases per million population per year, with an average age at diagnosis of 60.4 years. The incidence increased over time, with significantly higher incidence rates documented in British Columbia and Nova Scotia (9.3 cases per million population each). Closer examination revealed clustering of cases in various urban centres and self-identified lgbtq communities in Toronto, Montreal, and Vancouver. Discussion: This study provides, for the first time, a comprehensive analysis of the burden of anal scc in Canada, identifying susceptible populations and shedding light onto novel avenues of research to lower the incidence of anal cancer throughout the country.

Indexed as

Anus NeoplasmsCanadaCarcinoma, Squamous CellFemaleGeographyHumansMaleMiddle AgedRegistriesRisk FactorsAnal canceranal squamous cell carcinomaanorectal adenocarcinomaanorectal cancerepidemiologygeographic clusteringincidence in Canada

Identifiers

PMID32669936
PMCPMC7339845
OpenAlexW3042788414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.